2007Unpublished venueRequires access

Iminosugar Inhibitors for Substrate Reduction Therapy for the Lysosomal Glycosphingolipidoses

Terry D. Butters

Open publisher page 7 citations

Abstract

This chapter contains sections titled: Glycolipid lysosomal storage diseases Options for glycosphingolipidosis therapy Iminosugars for substrate reduction therapy Iminosugars as inhibitors of glycolipid biosynthesis SRT combination therapy Prospects for iminosugars as therapeutics References

About this research paper

What this paper is about

This chapter contains sections titled: Glycolipid lysosomal storage diseases Options for glycosphingolipidosis therapy Iminosugars for substrate reduction therapy Iminosugars as inhibitors of glycolipid biosynthesis SRT combination therapy Prospects for iminosugars as therapeutics References

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter contains sections titled: Glycolipid lysosomal storage diseases Options for glycosphingolipidosis therapy Iminosugars for substrate reduction therapy Iminosugars as inhibitors of glycolipid biosynthesis SRT combination therapy Prospects for iminosugars as therapeutics References

Key concepts: Iminosugar, Substrate reduction therapy, Glycolipid, Substrate (aquarium), Reduction (mathematics), Chemistry, Medicine, Biochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Iminosugar Inhibitors for Substrate Reduction Therapy for the Lysosomal Glycosphingolipidoses — Research Paper | ScholarLens